Good practice (GxP) compliance has a reputation for slowing enterprise resource planning (ERP) deployments to a crawl. Adrian Vazquez, a program execution and compliance specialist, thinks that reputation is misplaced. The delay is not compliance – it is the consistent failure to plan for it. “When you fail to plan, you plan to fail,” Vazquez says. “You’re not late because of regulatory compliance. You’re late because you failed to plan.” GxP is non-negotiable in pharmaceutical and life sciences. What is negotiable is when it enters the project conversation. Most organizations make that decision too late and spend the rest of the deployment paying for it.
The Planning Gap That Creates Every Bottleneck
The root cause is that people brought in to plan ERP deployments typically lack a regulatory compliance background. GxP requirements are treated as an addendum rather than a design input, which means they surface after timelines have been set, resources have been allocated, and commitments have been made to stakeholders who are not interested in rescheduling.
The consequences are predictable. Teams scramble to meet deployment deadlines while simultaneously trying to satisfy regulatory requirements that were never factored into the schedule. The quality assurance (QA) and validation teams, who had no input into the original plan, absorb the full pressure of that gap at the worst possible moment. “Usually when it comes down to the stretch, and the system needs to go live, that is a very stressful time for QA and validation teams,” Vazquez says. They are not failing, but they are compensating for decisions made without them.
The fix is not to provide more compliance resources at the back end. It involves the GxP compliance team, the QA team and the validation team from the very beginning of any IT deployment project. Not after plans are finalized or when timelines start slipping. “If you don’t involve them,” Vazquez says, “you’re going to suffer the consequences.” The organizations that have internalized this are the ones that consistently deliver compliant systems on schedule. The ones that have not keep arriving at the same crisis.
From Paperwork to Live Evidence
Regulators are moving away from documentation-heavy compliance models toward live evidence, a transition driven by the framework known as Computer Software Assurance (CSA). Rather than generating extensive paper trails to demonstrate compliance, CSA asks organizations to demonstrate it through real-time evidence embedded in the system itself. Pharma has historically maintained a strong compliance track record, and many organizations are already implementing CSA practices. The significant benefit is agility. “With CSA comes agility and the ability to move faster,” Vazquez says.
Organizations that adapt to this model are building a compliance capability that accelerates delivery rather than constraining it. The shift from paperwork to live evidence is, ultimately, a shift toward a more sustainable and operationally integrated approach to compliance.
AI Will Reshape the Entire Framework
Looking five years ahead, Vazquez predicts that artificial intelligence (AI) will be embedded in every component of the GxP compliance framework. Not as a supplementary tool, but as a foundational element of how compliance is designed, monitored, and demonstrated.
The window to build organizational fluency, test use cases, and develop governance frameworks around AI-assisted compliance is open today. It will not stay that way. Compliance does not have to slow delivery. Planned correctly, governed rigorously, and supported by the right teams from the outset, it is one of the most powerful levers an organization in a regulated industry has for building trust.
Follow Adrian Vazquez on LinkedIn for more insights on GxP compliance, ERP program execution, and technology deployment in regulated industries.
